Jonathan Dowdall has denied that he discussed mass murder with Gerard Hutch during secretly recorded conversations.
BBC News Dublin Correspondent
In the recordings, Mr Hutch can be heard telling Dowdall that "these three yokes were throwing up either way" as "a present". Mr Hutch can also be heard saying: "Twelve months time there's two RUC men dead and them things ballistically traced."Mr Hutch then says any smart copper would then say it is "a joint yoke".
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Man murdered boy after stabbing mum then tried to flee England on dinghy - trialMan murdered boy, 15, after stabbing his mum before trying to flee England on a dinghy, trial hears
Read more »
Woman to face trial over alleged attempted murder of two 10-year-old boysThe trial has been planned for next year
Read more »
Crumbling courts in England and Wales exacerbate trial delays, report reveals\n\t\t\tGet local insights from Lisbon to Moscow with an unrivalled network of journalists across Europe,\n\t\t\texpert analysis, our dedicated ‘Brussels Briefing’ newsletter. Customise your myFT page to track\n\t\t\tthe countries of your choice.\n\t\t
Read more »
Long-term Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical TrialThis secondary analysis of an ongoing adaptive platform trial examines the effect of multiple interventions for critically ill adults with COVID-19 on longer-term outcomes.
Read more »
Gabapentinoids for Pain: A Review of Published Comparative Effectiveness Trials and Data Submitted to the FDA for Approval - DrugsUse of the gabapentinoids for pain continues to increase. In 2018, the US Food and Drug Administration (FDA) strengthened the warnings for both gabapentin and pregabalin to emphasize the central nervous system side effects and the risk of respiratory depression, especially when combined with other centrally acting drugs. We reviewed the published comparative effectiveness literature for gabapentinoids for pain as well as all trials (published and unpublished) used by the FDA for the approval of the five pain indications for these agents (one for gabapentin, four for pregabalin). Among the findings of interest are the fact that the FDA rejected the application for gabapentin for diabetic peripheral neuropathy based on the risk versus benefit profile of that drug in the clinical trials that were submitted by the manufacturer. Additionally, both the comparative effectiveness trials as well as the studies used by the FDA tend to be short in duration and show only modest pain benefits for the gabapentinoids. The placebo response in these trials was frequently one-third to one-half as great as the pain benefit demonstrated by the gabapentinoid. Based on the available clinical trial evidence, we feel prescribers should be cautious when using gabapentinoids for pain, particularly when using these agents for a prolonged period or when combined with other, centrally acting agents.
Read more »